REFERENCES
- Teofili L, Giona F, Martini M, Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. J Clin Oncol. 2007;25:1048–1053.
- Dror Y, Blanchette VS. Essential thrombocythaemia in children. Br J Haematol. 1999;107:691–698.
- Hasle H. Incidence of essential thrombocythaemia in children. Br J Haematol. 2000;110:751–751.
- Randi ML, Putti MC, Fabris F, Features of essential thrombocythaemia in childhood: a study of five children. Br J Haematol. 2000;108:86–89.
- El-Moneim AA, Kratz CP, Boll S, Essential versus reactive thrombocythemia in children: retrospective analyses of 12 cases. Pediatr Blood Cancer. 2007;49:52–55.
- Papageorgiou T, Theodoridou A, Kourti M, Childhood essential thrombocytosis. Pediatr Blood Cancer. 2006;47:970–971.
- 7. Passamonti F, Rumi E, Pietra D, Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34(+) cells into peripheral blood in myeloproliferative disorders. Blood. 2006;107:3676–3682.
- Tamary H, Yaniv I, Stein J, A clinical and molecular study of a bedouin family with dysmegakaryopoiesis, mild anemia, and neutropenia cured by bone marrow transplantation. Eur J Haematol. 2003;71:196–203.
- Swerdlow SH, Campo E, Harris NL. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.
- Harrison CN, Bareford D, Butt N, Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010;149:352–375.
- Michiels JJ, VanGenderen PJJ, Lindemans J, Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia. Leuk Lymphoma. 1996;22:47–56.
- Michiels JJ. Erythromelalgia and thrombocythemia: a disease of platelet prostaglandin metabolism—thesis, Rotterdam, 1981. Semin Thromb Hemost. 1997;23:335–338.
- Tefferi A, Fonseca R, Pereira DL, A long-term retrospective study of young women with essential thrombocythemia. Mayo Clin Proc. 2001;76:22–28.
- Beer PA, Erber WN, Campbell PJ, How I treat essential thrombocythemia. Blood. 2011;117:1472–1482.
- Alvarez-Larran A, Cervantes F, Bellosillo B, Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients. Leukemia. 2007;21:1218–1223.
- Passamonti F, Rumi E, Arcaini L, Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients. Haematologica. 2008;93:1645–1651.